tbuckley/cabot-search huggingface dataset:
A Sound Economic Basis for Schools of Nursing, and Other Addresses.
Journal: JAMA (1927)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Angiotensin AT1 receptor antagonism and ACE inhibition: comparison of effects on functional and morphological parameters of hypertensive myocardial remodeling in stroke-prone SHRs Alexander Reinecke, Marc Dorenkamp, Quinqui Xia, Christian Storz, Susanne Penz, Harro Bitterling, Annegret Blume, R�diger W.R. Simon and Thomas Unger. Institute of Pharmacology, University of Kiel, Kiel, Germany, Clinic of Cardiology; University of Kiel, Kiel, Germany
Journal: Journal of the American College of Cardiology (2001)
Princess Abra
Authors: Paul Moorehead
Journal: Annals of Internal Medicine (2008)

On Being a Doctor1 January 2008Princess AbraPaul Moorehead, MDPaul Moorehead, MDFrom Memorial University of Newfoundland, St. John's, Newfoundland and Labrador A1B 3V6, Canada.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-148-1-200801010-00011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Once upon a time, Abra and I met in the emergency room. She had no hair and the side of her head was scarred from surgery, but she was pretty anyway. Soft in her voice and sweet of nature, she was helpful as I examined her, even though she wasn't feeling well. Abra wore her toque elegantly, as though it were a crown.This is the kind of child who gets cancer.Abra had a brain tumor. Most of it had been cut out, and what remained had been irradiated. Now she was being given chemotherapy, a brew of poisons ... Author, Article, and Disclosure InformationAffiliations: From Memorial University of Newfoundland, St. John's, Newfoundland and Labrador A1B 3V6, Canada.Corresponding Author: Paul Moorehead, MD, Children's Hospital of Eastern Ontario, Room 5109, 401 Smyth Road, Ottawa, Ontario K1H 8L1, Canada; e-mail, [email protected]com. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 January 2008Volume 148, Issue 1Page: 80KeywordsChemotherapyDrugsEmotionsFeversHereditary nonpolyposis colorectal cancerMorphineShinglesSleepSurgery ePublished: 1 January 2008 Issue Published: 1 January 2008 Copyright & PermissionsCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
A Phase I Study of the Vascular Disrupting Combretastatin, OXi4503, in Patients with Relapsed and Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
Authors: Christopher R Cogle, Andres Gonzalez, Leslie Pettiford, Amy Meacham, Elizabeth Wise, Maxim Norkin, David Chaplin, Jai Balkissoon, Jack W Hsu, Randy A Brown, John W Hiemenz, John R Wingard
Journal: Blood (2012)
Distinguishing between salt poisoning and hypernatraemic dehydration in children
Journal: BMJ (2003)

attested.Remarkably overlooked for purposes of national reconciliation, this history still remains deeply present to many South Africans and explains much of the mistrust towards Western science, medicine, and public health.An understandable defiance is thus an important element of what is usually termed denial. 21In fact, denial-a common response among people facing an intolerable situation-has two facets. 22One is a denial of reality: a reaction that something can't be true, that it is not possible.The other is a denial of the unacceptable: a reaction that something is not normal, that although it exists it should not.Both facets are involved in the denial of the reality of HIV/AIDS.It is difficult for anybody-even a state leader-to fully comprehend the magnitude of the epidemic and its demographic consequences, such as the loss of 20 years of life expectancy within two decades.Also, it is seen as morally unacceptable that a plague can affect the population so massively and so unequally precisely at the point when democracy has at last been achieved-in what seems a remorseless prolongation of the suffering of the weakest people in society.
The Chest in Children Roentgenologically Considered.
Journal: JAMA (1931)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Management of Head and Neck Cancer: A Multidisciplinary Approach
Authors: Walter G. Gunn
Journal: JAMA (1985)

Professors Rodney Million and Nicholas Cassisi of the University of Florida, Gainesville, have written and illustrated a superb volume on head and neck cancer that will at once become the standard of reference in that field. They have collaborated to write most of the chapters themselves and have chosen 17 other contributors who have dealt well with their special subjects. In their choice of contributors, the editors have been fortunate; ancillary chapters are well done and comprehensive. I particularly liked a perceptive and thorough analysis by Parsons on effects of irradiation on normal tissues. For the technique buff, the details of radiation field placement in the early chapters are a joy. The whys and wherefores are explained, as well as the hows. Such attention to detail is vital in this field, where thoroughness can mean the difference between successful treatment and a marginal recurrence or serious complication. Photographs and line
Angiotensin II, Digital Blood Flow and the Pre- and Postcapillary Blood Vessels of Man
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Corrections
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Picture This
Authors: Rebecca Voelker
Journal: JAMA (1999)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dimethyl Sulfoxide
Authors: Morton A. Stenchever
Journal: JAMA (1967)

<h3>To the Editor:—</h3> We would like to make a comment on the recent decision made by the Food and Drug Administration to allow further clinical evaluation of dimethyl sulfoxide in the conditions scleroderma, persistent herpes zoster, and severe rheumatoid arthritis (<i>FDA News</i>Release, Dec 22, 1966). The FDA has laid down strict guidelines for the use of this substance in patients suffering from these conditions and has also mentioned the fact that dimethyl sulfoxide may be toxic to embryos. We feel, however, that the potential effect of dimethyl sulfoxide as a teratogen should be reemphasized and kept specifically in mind by investigators about to embark on studies involving this agent. In a letter to the editor in<i>Lancet</i>(<b>1</b>:208, 1966), Dr. Vergil H. Ferm gave evidence that dimethyl sulfoxide was responsible for the development of anencephaly in golden hamster fetuses when the substance had been administered to the pregnant
Hunterian Lectures on the Experience of St. George's Hospital in Laparotomy; Exclusive of Gynaecological Operations, from 1888 to 1894 Inclusive: Delivered at St. George's Hospital Medical School
Authors: T. Holmes
Journal: BMJ (1895)

K what drew the patient's attention to there being something wrong, and in only 2 of the cases of cancer was pain a prominent symptom at any time.In 3 of the 11 cases the disease appears to have lain dormant for a year or longer.and in only 1 can the patient suggest any cause, either for the original development or for the activity of the growth, and the cause given in 1 of the cyst cases was a blow some months pre- ,Viously.In 3 of the cases, and these were all cancer, retraction of the nipple was an early symptom.In no case was -disease of the nipple recorded as an antecedent condition.I have said that in only 3 of these cases was there any difficulty in coming to a conclusion as to whether the disease was malignant or not, and we may quickly reduce that to 2, because in 1, that of subacute mastitis, although on first ex- amining the patient there was found an ill-defined non-circumscribed lump in the breast, tender to the touch, and this tenderness extending into the axilla, and a history of darting pains and a marked family history of cancer, the course of the disease had been too rapid for an actual tumour to have developed, and the idea of an inflammatory swelling was up- ,permost in our minds, which a few hours' observation proved this to be.The 2 cases that presented real difficulty were Nos. 3 and 4, both of which turned out to be malignant, and in the case of No. 4 it was only a microscopical examination that determined the nature of the disease.To recognise malignant disease in its early stage is of the utmost import- ance, because when it has spread to the adjacent glands the -chance of cure is very much lessened even if they be thoroughly removed, and though some may say, If in doubt ,operate, I think we should, to say the least.feel dissatisfied wvith ourselves if we removed a breast and then found that -we might have saved it.What then are the conditions most likely to be mistaken for cancer?I think they are the foltowing-chronic mastitis, chronicabscess, cystic disease deep in the breast, and sometimes, but not often, fibro-adenoma.The chief signs of cancer in the early stage are a patient ever, or at any rate not far from, 40 years of age, often one -whose health has previously been excellent, a rapidly en- larging diffase indurated, inelastic tumour in the breast, sometimes attended with lancinating pains, but often pain- 'less, sometimes retraction of nipple or the level of the two nipples not the same.In some cases when it is deeply seated <the breast does not glide freely over the subjacent tissues, and -when it is superficial the skin gets early adherent, and often on manipulation the skin puckers; sometimes, even fairly -early in the disease, there is enlargement of the axillary :glands.All the above signs may be present in the first
Secondary resection in a general mCRC population with cetuximab-based first-line treatment: Interim analysis of the German noninterventional study ERBITAG.
Authors: Friedrich Overkamp, Thomas Goehler, Gernot Reich, Michael Schwerdtfeger, Patrick Stuebs, Karsten G Stenzel, Ulf P Neumann
Journal: Journal of Clinical Oncology (2013)

590 Background: Resection of liver and/or lung metastases (LM) are a potentially curative option for patients with mCRC. Cetuximab in combination with irinotecan- or oxaliplatin-based chemotherapy has shown to increase the resection rate of primarily unresectable LM in mCRC patients. After approval of cetuximab in Germany for first-line treatment of pts with unresectable mCRC, this noninterventional study was initiated to evaluate safety and efficacy of cetuximab in combination with various first-line chemotherapy regimens in patients with unresectable mCRC. Methods: We conducted an interim analysis of the first 124 fully documented pts to evaluate the response rate (RR) and resection rate of LM. Enrolment was restricted to pts with mCRC with proven KRAS wildtype mutation status without prior systemic treatment in the metastatic stage. Predefined endpoints were amongst others RR, LM resection rate, TTF, PFS, OS, and safety. Results: From May 2010 to May 2012 360 eligible pts were enrolled at 109 sites (75% office-based physicians), documentation for 124 was finalised (data cut-off for this analysis 03 May 2012) and evaluated. The median age was 68 [range 34-84] years, ECOG performance status was 0, 1, 2 in 29%, 60%, and 9% of pts, respectively, in 2% of pts ECOG performance status was missing. Resection rate was 18.5% (n=23) performed at 18 sites with 16.9% R0 resections (n=21). 42% of pts (n=52) had liver-limited disease (LLD). Resection rate in pts with LLD was 34.6% (n=18) with a 30.6% R0-resection rate (n=16). Median treatment duration from start of cetuximab-based therapy to resection of LM was 3.7 months [0.7-12.0]. Objective response rate was 46.8% (CR 4.8%, PR 41.9%) and 59.6% (CR 5.8%, PR 53.8%) for pts with LLD. Conclusions: In a clinical practice setting cetuximab-based first-line treatment of an unselected population with KRAS wildtype mCRC resulted in an R0-resection rate of 16.9% overall, and 30.6% for LLD pts. These data compare fairly well with data from clinical trials: CRYSTAL, OPUS, and CELIM.
Dementia
Authors: Nicholas A. Vick
Journal: JAMA (1972)

This is the ninth volume of the Contemporary Neurology Series, whose black-bound spines seem to be omnipresent on the shelves of many neurologists and neurology residents. Wells' introductory chapter, written with a perspective that is admirably both neurologic and psychiatric, says well in brief what is discussed at length in subsequent chapters on the clinical aspects of dementia. Much of this standard descriptive material seems aimed at the first-year neurology resident, but is well written by skilled students of the subject. Chapters 5 through 8 are up-to-date, if brief, reviews of the electroencephalography, radiology, pathology (including ultrastructural alterations), and biochemistry of dementia. In this latter topic, unfortunately, as the authors of the chapter note, far too little is yet known. The volume ends with a lucid chapter by Haase on the differential diagnosis of the dementing disorders, which emphasizes the importance of searching for a treatable metabolic or structural cause
The demise of nursing in the United Kingdom: a warning for medicine
Authors: Linda Shields, Roger Watson
Journal: Journal of the Royal Society of Medicine (2007)

The 19th century teaches us that nurses must be central to the running of all aspects of hospitals, not just those areas deemed appropriate by the medical profession. This will require not only improved nursing leadership but also enhanced opportunities for nurses to realise their potential through education and training. 1 (p. 1396)
New Direction For Cancer Research
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Electric and Magnetic Field Exposures for People Living near a 735-Kilovolt Power Line
Authors: Patrick Levallois, Denis Gauvin, Josee St-Laurent, Suzanne Gingras, Jan E. Deadman
Journal: Environmental Health Perspectives (1995)

The purpose of this study was to assess the effect of a 735-kV transmission line on the electric and magnetic field exposures of people living at the edge of the line's right of way. Exposure of 18 adults, mostly white-collar workers, living in different bungalows located 190-240 feet from the line (exposed subjects) was compared to that of 17 adults living in similar residences far away from any transmission line. Each subject carried a Positron meter for 24 hr during 1 workday, which measured 60-Hz electric and magnetic fields every minute. All measurements were carried out in parallel for exposed and unexposed subjects during the same weeks between September and December. During measurements the average loading on the line varied between 600 and 1100 A. The average magnetic field intensity while at home was 4.4 times higher among exposed subjects than unexposed (7.1 versus 1.6 mG, p = 0.0001) and 6.2 times higher when considering only the sleeping period (6.8 versus 1.1 mG, p = 0.0001). Based on the 24-hr measurement, average magnetic field exposure was three times higher among the exposed. Electric field intensity was also higher among the exposed while at home (26.3 versus 14.0 V/m, p = 0.03). Magnetic field intensity among the exposed was positively correlated with the loading on the line (r = 0.8, p = 0.001). Percentage of time above a magnetic field threshold (2 mG or 7.8 mG) was a good indicator to distinguish the two types of exposure.(ABSTRACT TRUNCATED AT 250 WORDS)
QUINIDIN IN THE TREATMENT OF THE CARDIAC IRREGULARITIES
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal